BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29632058)

  • 1. Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ.
    Hassett MJ; Jiang W; Hughes ME; Edge S; Javid SH; Niland JC; Theriault R; Wong YN; Schrag D; Punglia RS
    J Natl Compr Canc Netw; 2018 Apr; 16(4):387-394. PubMed ID: 29632058
    [No Abstract]   [Full Text] [Related]  

  • 2. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
    Thompson AM; Clements K; Cheung S; Pinder SE; Lawrence G; Sawyer E; Kearins O; Ball GR; Tomlinson I; Hanby A; Thomas JSJ; Maxwell AJ; Wallis MG; Dodwell DJ;
    Eur J Cancer; 2018 Sep; 101():210-219. PubMed ID: 30092498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base.
    Flanagan MR; Rendi MH; Gadi VK; Calhoun KE; Gow KW; Javid SH
    Ann Surg Oncol; 2015 Oct; 22(10):3264-72. PubMed ID: 26202556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
    Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
    Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.
    Hillner BE; Desch CE; Carlson RW; Smith TJ; Esserman L; Bear HD
    J Clin Oncol; 1996 Jan; 14(1):70-7. PubMed ID: 8558224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women.
    Buscariollo DL; Cronin AM; Borstelmann NA; Punglia RS
    Breast Cancer Res Treat; 2019 Feb; 173(3):709-717. PubMed ID: 30406869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.
    Barbour S; Moore J; Dunn N; Effeney R; Harden H; McCarthy A; Walpole E; Lehman M
    Breast; 2017 Oct; 35():169-176. PubMed ID: 28756338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.
    Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA
    Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.
    Madubata CC; Liu Y; Goodman MS; Yun S; Yu J; Lian M; Colditz GA
    Breast Cancer Res Treat; 2016 Dec; 160(3):563-572. PubMed ID: 27771840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
    Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
    Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.
    Greenberg CC; Habel LA; Hughes ME; Nekhlyudov L; Achacoso N; Acton L; Schrag D; Jiang W; Edge S; Weeks JC; Punglia RS
    Ann Surg Oncol; 2014 Nov; 21(12):3766-73. PubMed ID: 24859938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.
    Pilewskie M; Olcese C; Eaton A; Patil S; Morris E; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2014 May; 21(5):1552-60. PubMed ID: 24385207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.
    Yang Y; Zhao X; Wang X; Jin K; Luo J; Yang Z; Mei X; Ma J; Shao Z; Zhang Z; Chen X; Guo X; Yu X
    Cancer Med; 2022 Jul; 11(14):2755-2766. PubMed ID: 35598318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
    Alaeikhanehshir S; Schmitz RSJM; van den Belt-Dusebout AW; van Duijnhoven FH; Verschuur E; van Seijen M; Schaapveld M; Lips EH; Wesseling J;
    Breast Cancer Res Treat; 2024 Feb; 204(1):61-68. PubMed ID: 37964135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiation therapy for breast ductal carcinoma in situ.
    Hathout L; Hijal T; Théberge V; Fortin B; Vulpe H; Hogue JC; Lambert C; Bahig H; Provencher L; Vavassis P; Yassa M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1058-63. PubMed ID: 24113057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.
    Pawloski KR; Tadros AB; Sevilimedu V; Newman A; Gentile L; Zabor EC; Morrow M; Van Zee KJ; Kirstein LJ
    Breast Cancer Res Treat; 2021 Apr; 186(3):617-624. PubMed ID: 33675490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.